SILENCE THERAPEUTICS
Silence Therapeutics plc is a United Kingdom-based ribonucleic acid (RNA) technology company. The Company is primarily involved in the research and development of pharmaceutical products. The Company's technology harnesses the body's natural mechanisms to create therapeutic effects within its own cells. The Company has a has a genetic toolkit with its own therapeutic payloads to modulate gene expression up as well as down in preclinical in vivo models, and delivery systems for various organs and cell types.
SILENCE THERAPEUTICS
Industry:
Biotechnology Health Care Information Technology Medical Therapeutics
Founded:
1999-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.silence-therapeutics.com
Total Employee:
11+
Status:
Active
Contact:
+4402037009711
Email Addresses:
[email protected]
Total Funding:
128.7 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Content Delivery Network Google Universal Analytics Domain Not Resolving Euro ReCAPTCHA Cloudflare SSL
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Future Medical Technologies
Future Medical Technologies is engaged in the development of its proprietary HydraCartilage technology.
Intellia Therapeutics
Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments.
Interline Therapeutics
Interline Therapeutics is a drug discovery platform that enables the company to map and correct dysfunctional protein communities.
NorInvents
NorInvents is a development company in the field of life science, which develops Drug Delivery platforms.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Current Employees Featured
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2009-12-16 | Intradigm Corporation | Intradigm Corporation acquired by Silence Therapeutics | N/A |
Investors List
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Post-IPO Equity - Silence Therapeutics
Adage Capital Management
Adage Capital Management investment in Post-IPO Equity - Silence Therapeutics
BVF Partners
BVF Partners investment in Post-IPO Equity - Silence Therapeutics
Consonance Capital Partners
Consonance Capital Partners investment in Post-IPO Equity - Silence Therapeutics
Great Point Partners
Great Point Partners investment in Post-IPO Equity - Silence Therapeutics
Mallinckrodt
Mallinckrodt investment in Post-IPO Equity - Silence Therapeutics
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2017-01-10 | Arrowhead Pharmaceuticals | Silence Therapeutics investment in Post-IPO Equity - Arrowhead Pharmaceuticals | 9.6 M USD |
Key Employee Changes
Official Site Inspections
http://www.silence-therapeutics.com Semrush global rank: 3.78 M Semrush visits lastest month: 3.57 K
Unable to get host informations!!!
More informations about "Silence Therapeutics"
About us - Silence Therapeutics
At Silence, our vision is to transform peoples’ lives around the world by silencing diseases through our precision engineered medicines and driving positive change for the communities around us.See details»
Silence Therapeutics - Wikipedia
Silence Therapeutics (Nasdaq: SLN ) is a London-based pharmaceutical company formed in 1994. The company has pioneered the development of short-interfering ribonucleic acid (siRNA) therapeutics for the treatment of rare diseases. Silence Therapeutics has offices in London, New Jersey, and Berlin, with its corporate headquarters located in Hammersmith, London. See details»
Silence Therapeutics Profile - Business Structure, Industry
Discover a detailed profile of Silence Therapeutics, including its core business, market segments, leadership roles, and geographic presence.See details»
Silence Therapeutics - About us - Executive Leadership …
He has recently served as Chairman of the Board of the National Pharmaceutical Council, a non-profit health policy research organization, and is a past …See details»
Silence Therapeutics - Crunchbase Company Profile
Silence Therapeutics plc is a United Kingdom-based ribonucleic acid (RNA) technology company. The Company is primarily involved in the research and …See details»
Silence Therapeutics plc (SLN) - Yahoo Finance
See the company profile for Silence Therapeutics plc (SLN) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Silence Therapeutics - Financial Details - Crunchbase
Feb 5, 2024 Silence Therapeutics is a drug development company with a proprietary genetic medicine platform.See details»
Silence Therapeutics (SLN) Company Profile & Description
Aug 8, 2025 Company profile for Silence Therapeutics plc (SLN) stock, with a description, list of executives, contact details and other key facts.See details»
Silence Therapeutics Halts Zerlasiran Phase 3 Despite …
Feb 28, 2025 Silence Therapeutics recently shared an update regarding its zerlasiran program, indicating a shift in its strategy for advancing this …See details»
Silence Therapeutics - News & Analysis - Crunchbase
Silence Therapeutics is a drug development company with a proprietary genetic medicine platform.See details»
Silence Therapeutics Plc - Drug pipelines, Patents, Clinical trials ...
May 7, 2025 Explore Silence Therapeutics Plc with its drug pipeline, therapeutic area, technology platform, 9 clinical trials, 120 news, and 54 literature, Disease Domain:Hemic and …See details»
Silence Therapeutics plc - LinkedIn
Silence Therapeutics plc | 12,834 followers on LinkedIn. Precision Engineered Medicines to Silence Diseases | Our 20-plus years of RNAi experience together with our validated mRNAi …See details»
Silence Therapeutics Reports First Quarter 2025 Financial Results …
May 8, 2025 Silence Therapeutics is a global clinical-stage biotechnology company committed to transforming people’s lives by silencing diseases through precision engineered medicines …See details»
Silence Therapeutics Company Profile - Office Locations ... - Craft
Nov 10, 2021 Silence Therapeutics has 5 employees across 5 locations and £43.26 m in annual revenue in FY 2024. See insights on Silence Therapeutics including office locations, …See details»
Silence Therapeutics Reports Second Quarter 2025 Financial …
Aug 7, 2025 LONDON-- (BUSINESS WIRE)-- Silence Therapeutics plc, Nasdaq: SLN (“Silence” or “the Company”), a global clinical-stage company developing novel siRNA (short interfering …See details»
Silence Therapeutics - Our Pipeline
We are developing a deep pipeline of innovative siRNAs based on our mRNAi GOLD™ platform for diseases with a genetic basis. The depth and versatility of our liver-targeting technology …See details»
Silence Therapeutics 2025 Company Profile: Stock ... - PitchBook
Information on stock, financials, earnings, subsidiaries, investors, and executives for Silence Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
What is Brief History of Silence Therapeutics Company?
Jul 24, 2025 Discover the history of Silence Therapeutics and how its commitment to gene silencing has contributed to the biotech landscape.See details»
Silence Therapeutics plc Overview | SignalHire Company Profile
Silence Therapeutics plc Overview Contact top employees from Silence Therapeutics plc Summary Silence Therapeutics plc is a public company that has been in the industry for 30 …See details»
Working at Silence Therapeutics Plc | Great Place To Work®
Why Work at Silence Therapeutics Plc? See what employees say about what makes Silence Therapeutics Plc a great workplace. These words are drawn from employee comments on the …See details»